Key terms

About CMPS

Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CMPS news

Apr 11 10:24am ET Here’s What You Missed in Cannabis, Psychedelics This Week Apr 04 11:06am ET Here’s What You Missed in Cannabis, Psychedelics This Week Apr 01 7:21am ET Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG) Apr 01 4:24am ET Compass Pathways initiated with an Overweight at Morgan Stanley Apr 01 4:17am ET Buy Rating on COMPASS Pathways: COMP360’s Market Potential and Promising TRD Therapy Mar 28 11:32am ET Rising High: Exclusive talk with financial services firm Safe Harbor Financial Mar 28 8:12am ET COMPASS Pathways Leadership Restructure and Board Reshuffle Mar 28 8:12am ET Compass Pathways co-founders depart from board, David Norton named interim chair Mar 21 10:52am ET Here’s What You Missed in Cannabis, Psychedelics This Week Mar 20 5:07am ET Analysts’ Top Healthcare Picks: Prime Medicine, Inc. (PRME), Alcidion Group Limited (AU:ALC) Mar 19 12:15am ET Buy Rating Affirmed for COMPASS Pathways Amid Promising Neuropsychiatric Treatment Advances Mar 14 11:15am ET Rising High: Exclusive talk with cannabis market research firm BDSA Mar 07 1:09pm ET Rising High: Exclusive talk with multi-state operator C3 Industries Mar 07 10:46am ET Rising High: Exclusive talk with vape tech developer Ispire Technology Mar 05 12:35pm ET COMPASS Pathways: A Buy Recommendation Anchored by Strong Cash Reserves and Strategic Collaborations Mar 01 11:25am ET Buy Rating Affirmed for COMPASS Pathways Amid Strategic Advances and Promising Clinical Trials Mar 01 7:55am ET Buy Rating on COMPASS Pathways: Overreaction Creates Investment Opportunity Amid Positive Trial Prospects Feb 29 4:50pm ET Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and COMPASS Pathways (CMPS) Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 29 7:10am ET Compass Pathways reports Q4 EPS (53c), consensus (33c) Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 15 10:57am ET Rising High: Exclusive talk with cannabis market research firm BDSA Feb 15 10:57am ET Rising High: Exclusive talk with cannabis market research firm BDSA Feb 08 11:22am ET Rising High: Exclusive talk with house of brands Carma HoldCo Feb 08 11:22am ET Rising High: Exclusive talk with house of brands Carma HoldCo Feb 01 11:35am ET Rising High: Exclusive talk with drug manufacturer Optimi Health Feb 01 11:35am ET Rising High: Exclusive talk with drug manufacturer Optimi Health Feb 01 11:21am ET Rising High: Exclusive talk with drug manufacturer Optimi Health Jan 25 11:09am ET Here’s What You Missed in Cannabis, Psychedelics This Week

No recent press releases are available for CMPS

CMPS Financials

1-year income & revenue

Key terms

CMPS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CMPS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms